Last updated: 2026-09-16 11:44:20. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
DarioHealth Corp. (DRIO) operates in the SURGICAL & MEDICAL INSTRUMENTS & APPARATUS sector and is listed on NASDAQ. The stock is currently priced at $6.76, with a market capitalisation of $69.48M and a P/E ratio of 0.01. Over the past 52 weeks, its price has ranged from $5.84 to $17.74. This page covers its latest market performance, valuation, price trends and company information.
$69.48M | |
$7.00 | |
$2,360.00 | |
$5.84 | |
$7.09 | |
5.15K | |
23.62K | |
0.01 | |
$17.74 | |
$5.84 | |
-- | |
-- |
DarioHealth Corp. (DRIO) is trading at $7.20 in pre-market trading as of 2026-09-15 23:31:00, up 1.55% ($0.11) from the previous close of $7.09
Pre-market trading shows how investors are pricing DRIO before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.
Over the past seven days, DarioHealth Corp. (DRIO) moved from $7.24 to $6.76, representing a decline of 6.63% ($0.48).
The stock traded between $6.53 and $7.30 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 20.44 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 7.7%
DRIO is currently trading at $6.76, placing it 7.7% of the way from its 52-week low of $5.84 to its 52-week high of $17.74. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.
| Industry | SURGICAL & MEDICAL INSTRUMENTS & APPARATUS |
| Employees | 165 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of DarioHealth Corp. (DRIO) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.